Walla Al-Hertani, MD, MS, FRCPC, FACMG

Adrenoleukodystrophy (ALD), Barth Syndrome, Biochemical Genetic Testing, Galactosemia, Genetic Disorders, Genetic Testing, Phenylketonuria PKU

Dr. Walla Al-Hertani is a Medical Biochemical Geneticist and a Clinical Geneticist with expertise in inborn errors of metabolism (IEMs) and a special interest in Lysosomal Storage Diseases and Glycogen Storage Diseases. Dr. Al-Hertani received her Doctor of Medicine degree from Dalhousie University in Halifax, Nova Scotia, followed by the completion of a Clinical Genetics residency at the University of Ottawa and a Medical Biochemical Genetics fellowship at the Hospital for Sick Children (SickKids) and the University of Toronto. Dr. Al-Hertani practiced as a Medical Biochemical Geneticist and a Clinical Geneticist at the Montreal Children’s Hospital and McGill University, followed by the Alberta Children’s Hospital in Calgary, Canada before relocating to Boston. Dr. Al-Hertani is the Director of the Metabolism Program and the Boston Children’s Lysosomal Disease (BoLD) Program and is actively involved in a number of clinical trials investigating innovative therapies for IEMs and rare diseases.

Dr. Al-Hertani sees patients in clinic at Boston Children’s Hospital.

< BACK TO DIRECTORY